INNOSC Theranostics and Pharmacological Sciences (ITPS) is a peer-reviewed and open-access journal, covering research across disciplines in all aspects of basic, experimental and clinical theranostics (therapeutic and diagnosis) and pharmacological sciences. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful research discoveries to researchers, academicians, clinicians, and the public worldwide.

The impact of theragnostics has displayed a great advancement to be utilized efficiently in the fields of therapeutics, medical diagnosis and the associated aspects. Achievement with theranostics has been driven by different approaches in inter- and multi-disciplinary sciences. These approaches are highly motivated in the creation of novel researches, attested by a complete platform for the medicine and diagnosis forms a path from the laboratory to clinics. As a consequence, the focuses on clinical biomarkers, imaging, drug and gene delivery, and a direction towards a personalized medicine became popularized. The major outcome of this journal is to be suitable for all levels of stakeholders and the eventual motto is bridging all disciplines and expanding knowledge sharing.

Pharmacology is a branch of medicine concerned with the uses, effects and modes of action of drugs. This medical science with the impact of understanding the biochemical and therapeutic process gives us the handle to solve the crucial illness or chronic condition in life. It is likewise the science considering the connections amongst chemicals and organisms coordinated to avert, enhance or cure the harmful outcomes of their infections, along these lines it gives prescription weapons against illnesses. The journal aims to publish and promote articles in the advances of pharmacological sciences through the evaluation by top scholars and encourage the translation of preclinical research to the clinical stage.

The journal publishes rigorously the peer-reviewed high-quality original research articles, reviews or mini-reviews, case reports, rapid communications, letters to the editor, preliminary data on innovative research and editorials in all aspects from the basic experiments to clinical phase trials on human diseases, ranging from molecular to higher animals. Furthermore, findings from theories to current cutting-edge technologies are welcomed. Appreciate the submissions of the following appropriate research topics but not limited to

• Therapeutics
• Medical Diagnosis
• In Vivoimaging
• In Vitrodiagnosis
• Medicinal Chemistry
• Cancer Molecular Targets and Therapeutics
• Drug Metabolism and Transport
• Drug and Gene Delivery
• Drug Discovery
• Biomarker Discovery
• Nanomedicine
• Translational Medicine
• Personalized Medicine
• Clinical Immunology
• Biomedical Research
• Pharmacological Sciences

Specifically, for the aspect of pharmacological sciences, the research areas may include but not limited to the following:

• Nano-pharmacology (Nanomaterial-Based Treatment)
• Cardiovascular and Smooth Muscle Pharmacology
• Neuropharmacology
• Gastrointestinal Pharmacology
• Ethnopharmacology
• Experimental Pharmacology
• Inflammation Pharmacology
• Obstetric and Pediatric Pharmacology
• Pharmaceutical Medicine and Outcomes Research
• Pharmacogenetics and Pharmacogenomics
• Pharmacology of Anticancer Drugs
• Pharmacology of Ion Channels and Channelopathies
• Predictive Toxicology
• Respiratory Pharmacology
• Molecular and Cellular Pharmacology